This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Stock Market Today: Dow Jones Futures Are Down.

Stocks in this article: HCMLYLFRGYVIVHYRBXLYDSKYF

TheStreet's SpeedDesk Pre-Market Newsletter

Monday, April 7, 2014

STOCK MARKET FUTURES TODAY

As of 8:45 a.m., the Dow Jones futures were down -50.00, the S&P futures were down -7.20, and the Nasdaq futures were down -29.00.

Here's Why: U.S. stocks were set for a lower open today, putting the S&P 500 on track for its third straight decline, as weakness in momentum names that sent the Nasdaq and benchmark S&P index to their worst drop since February in the prior session appeared poised to continue.

OVERSEAS MARKETS TODAY

In Europe, the FTSE 100 Index was down -54.98, the CAC 40 Index was down -33.68, and the Deutsche Boerse AG German Stock Index DAX was down -148.50.

Here's why: European equities retreated on Monday after a three-week rally, with technology shares falling the most on concern they had advanced too far, too fast and a correction was due.

In Asia, the Nikkei 225 fell -254.92 and the Hong Kong Hang Seng Index closed down -132.93.

Here's why: Japan's Nikkei share average fell to a one-week low today, dragged down by tech shares following a slide on Wall Street, while a strong yen hit exporters to round out a harsh day for the market. 

COMPANY NEWS

Cement makers Holcim (HCMLY) and Lafarge (LFRGY) have agreed to an all-share merger of equals that will create a company with over $40 billion in annual sales and a market cap of $50 billion.

Vivendi (VIVHY) will sell its SFR unit to Luxembourg-based cable and mobile provider Altice despite Bouygues sweetening its offer for the mobile business at the last minute. Altice will give Vivendi a 20% stake in a company that will be created via the merger of SFR and Altice's French Numericable subsidiary. The entire deal is worth $23.3 billion.

Sun Pharmaceutical Industries will acquire Ranbaxy Laboratories (RBXLY) for $3.2 billion in an all-stock deal that will create the world's fifth-largest generic-drug maker Ranbaxy, which is owned by Japan's Daiichi Sankyo (DSKYF) banned from selling ingredients to the U.S., while Sun's Karkhadi facility is also not allowed to export products to the U.S.

NEWS WEBSITES

Yahoo (YHOO) plans to acquire original programming usually seen on high-end cable-TV networks and streaming services like Netflix (NFLX), the Wall Street Journal reports

Mallinckrodt (MNK) will buy Questcor Pharmaceuticals (QCOR) for $5.6 billion to add specialty drugs in the latest industry deal that moves a U.S. company to Ireland for a lower tax rate, Bloomberg reports

Energen Corp. (EGN) agreed to sell its Alabama natural gas utility to the Laclede Group (LG) for $1.28 billion in cash, Bloomberg reports

Caterpillar (CAT) is likely to face tougher scrutiny from the IRS after being grilled over its tax strategies at a U.S. Senate subcommittee hearing last week, some tax experts say, the Wall Street Journal reports

Credit Suisse (CS) faces the threat of a new investigation into its role in helping wealthy Americans avoid paying taxes after New York state's top financial regulator requested documents from the Swiss bank, Reuters reports

IPO WATCH

No IPOs are expected to price on Monday.

EARNINGS

After today's market close, notable earnings include: A Schulman (SHLM), Novagold Resources (NG), and Genco Shipping & Trading (GNK)

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,399.67 +19.26 0.12%
S&P 500 1,904.01 +17.25 0.91%
NASDAQ 4,316.0740 +57.6360 1.35%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs